2022-2029年全球避孕药物市场规模研究和预测，按产品、分销渠道和区域分析

2021年，全球避孕药市场价值约为165.9亿美元，预计在2022-2029年的预测期内将以超过7.4%的健康增长率增长。避孕药是女性为控制生育而消费的。避孕药市场正在扩大，因为意外怀孕的发生率越来越高，性传播疾病（STD）的流行率越来越高。然而，不孕症发病率的上升和与使用避孕药物和设备有关的不良反应可能会阻止市场增长。

在整个预测期内，市场增长预计将受到性传播疾病（STD）发病率上升和未满足避孕药物和设备需求的妇女人数增加的推动。根据世界卫生组织的数据，2019年全球有近11亿育龄妇女（15至49岁）需要计划生育。其中超过8.42亿人使用避孕技术进行计划生育，其中有2.7亿人的避孕需求没有得到满足。此外，联合国经济和社会事务部人口司报告说，在2019年，世界上有19亿育龄妇女（15-49岁）。约有8000万人使用常规方法，而约有8.42亿妇女使用现代避孕方法，包括口服药物和注射剂。此外，人们对避孕药物的认识不断提高，导致产品的需求，为市场创造了有利可图的增长。除此以外，发达国家广泛的报销政策预计将在预测期内推动市场的采用率。

全球避孕药物市场研究的主要地区包括亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于品牌产品的主导地位和该地区日益增长的疾病流行率，北美在收入方面主导了市场。而亚太地区在预测期内预计将以最高的复合年增长率增长，原因是老年病和目标人群的增加，生物仿制药开发合作的数量增加，主要参与者的地理扩张，以及政府和非营利组织对市场空间的积极参与。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的质量和数量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

• 市场简介
• 2019-2029年全球及细分市场的估计和预测
  • 2019-2029年，按地区分類的避孕药物市场
  • 2019-2029年，按产品划分，避孕药市场
  • 2019-2029年避孕药市场，按分销渠道划分
• 主要趋势
• 估算方法
• 研究假设

第二章：全球避孕药物市场的定义和范围

• 本研究的目的
• 市场定义和范围
  • 研究的范围
  • 行业演变
• 研究中考虑的年份
• 货币转换率

第三章：全球避孕药市场动态

• 避孕药市场影响分析(2019-2029)
  • 市场驱动力
    • 政府和非政府组织推广避孕方法的倡议
    • 意外怀孕的发生率不断上升
  • 市场挑战
    • 不孕不育症的发病率上升
    • 与使用避孕药物和装置有关的不良反应
  • 市场机会
    • 性传播疾病（STD）的发病率不断上升

第四章：全球避孕药物市场行业分析

• 波特的5力模型
  • 供应商的议价能力
  • 买方的讨价还价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争性的竞争
• 波特五力模型的未来方法（2019-2029年）
• PEST分析
  • 政治因素
  • 经济
  • 社会
  • 技术
• 最佳投资机会
• 最佳策略
• 行业专家展望
• 分析师建议和结论

第五章：风险评估：COVID-19的影响

• 评估COVID-19对行业的整体影响
• COVID-19前和COVID-19后的市场情况

第六章：全球避孕药物市场，按产品分类

• 市场简介
• 全球避孕药物市场，按产品，性能-潜力分析
• 2019-2029年全球避孕药物市场按产品的估计和预测
• 避孕药市场，細項分析
  • 口服
  • 注射式
  • 药片

第7章 ：全球避孕药物市场，按分销渠道划分

• 市场简介
• 按分销渠道分類的全球避孕药物市场，表现 - 潜力分析
• 2019-2029年全球避孕药物市场按分销渠道的估计和预测
• 避孕药市场，細項分析
  • 医院药房
  • 零售药店
  • 诊所
  • 在线渠道
  • 公共渠道和非政府组织
  • 其他渠道

第八章：全球避孕药具市场，区域分析

• 避孕药市场，区域市场简介
• 北美洲
  • 美国
    • 产品分类估计和预测，2019-2029年
    • 2019-2029年分销渠道细分估计和预测
  • 加拿大
• 欧洲避孕药物市场简介
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 欧洲其他地区
• 亚太地区避孕药物市场简介
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 亚太其他地区
• 拉丁美洲避孕药物市场简介
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 世界其他地区

第九章：竞争情报

• 顶级市场战略
• 公司简介
  • Piramal Enterprises Ltd.
    • 关键信息
    • 概况
    • 财务（取决于数据的可用性）
    • 产品摘要
    • 近期发展情况
  • Organon group of companies
  • Johnson & Johnson Services, Inc.
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Amneal Pharmaceuticals, Inc.
  • Bayer AG
  • Agile Therapeutics

第十章 ：研究过程

• 研究过程
  • 资料探勘
  • 数据分析
  • 市场评估
  • 验证
  • 出版
• 研究属性
• 研究假设

Global Contraceptive Drugs Market is valued approximately USD 16.59 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Contraceptive Drugs are consumed by female for birth control. The Contraceptive Drugs market is expanding because of factors such as increasing prevalence of unwanted pregnancies and increasing prevalence of sexually transmitted diseases (STDs). However, rising prevalence of infertility and adverse effects associated with the use of contraceptive drugs and devices may halt market growth.

Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15-49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.

The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

• Piramal Enterprises Ltd.
• Organon group of companies
• Johnson & Johnson Services, Inc.
• AbbVie Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Amneal Pharmaceuticals, Inc.
• Bayer AG
• Agile Therapeutics.

Recent Developments in the Market:

• In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
• In January 2020, Bayer AG and Dare Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.

Global Contraceptive Drugs Market Report Scope:

• Historical Data 2019-2020-2021
• Base Year for Estimation 2021
• Forecast period 2022-2029
• Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered Product, Distribution Channel, Region
• Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

• Oral
• Injectable
• Patches

By Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channels & NGOs
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
  • 1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Contraceptive Drugs Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Contraceptive Drugs Market Dynamics

• 3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Government and NGO initiatives to promote contraceptive methods
    • 3.1.1.2. Increasing prevalence of unwanted pregnancies
  • 3.1.2. Market Challenges
    • 3.1.2.1. Rising prevalence of infertility
    • 3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)

Chapter 4. Global Contraceptive Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Contraceptive Drugs Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Contraceptive Drugs Market by Product, Performance - Potential Analysis
• 6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
• 6.4. Contraceptive Drugs Market, Sub Segment Analysis
  • 6.4.1. Oral
  • 6.4.2. Injectable
  • 6.4.3. Patches

Chapter 7. Global Contraceptive Drugs Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Contraceptive Drugs Market, Sub Segment Analysis
  • 7.4.1. Hospital Pharmacy
  • 7.4.2. Retail Pharmacy
  • 7.4.3. Clinics
  • 7.4.4. Online Channels
  • 7.4.5. Public Channels & NGOs
  • 7.4.6. Others

Chapter 8. Global Contraceptive Drugs Market, Regional Analysis

• 8.1. Contraceptive Drugs Market, Regional Market Snapshot
• 8.2. North America Contraceptive Drugs Market
  • 8.2.1. U.S. Contraceptive Drugs Market
    • 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Contraceptive Drugs Market
• 8.3. Europe Contraceptive Drugs Market Snapshot
  • 8.3.1. U.K. Contraceptive Drugs Market
  • 8.3.2. Germany Contraceptive Drugs Market
  • 8.3.3. France Contraceptive Drugs Market
  • 8.3.4. Spain Contraceptive Drugs Market
  • 8.3.5. Italy Contraceptive Drugs Market
  • 8.3.6. Rest of Europe Contraceptive Drugs Market
• 8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
  • 8.4.1. China Contraceptive Drugs Market
  • 8.4.2. India Contraceptive Drugs Market
  • 8.4.3. Japan Contraceptive Drugs Market
  • 8.4.4. Australia Contraceptive Drugs Market
  • 8.4.5. South Korea Contraceptive Drugs Market
  • 8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
• 8.5. Latin America Contraceptive Drugs Market Snapshot
  • 8.5.1. Brazil Contraceptive Drugs Market
  • 8.5.2. Mexico Contraceptive Drugs Market
  • 8.5.3. Rest of Latin America Contraceptive Drugs Market
• 8.6. Rest of The World Contraceptive Drugs Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Piramal Enterprises Ltd.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Organon group of companies
  • 9.2.3. Johnson & Johnson Services, Inc.
  • 9.2.4. AbbVie Inc.
  • 9.2.5. Pfizer Inc.
  • 9.2.6. Teva Pharmaceutical Industries Ltd.
  • 9.2.7. Viatris Inc.
  • 9.2.8. Amneal Pharmaceuticals, Inc.
  • 9.2.9. Bayer AG
  • 9.2.10. Agile Therapeutics

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Contraceptive Drugs Market, report scope
• TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
• TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Contraceptive Drugs Market, research methodology
• FIG 2. Global Contraceptive Drugs Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Contraceptive Drugs Market, key trends 2021
• FIG 5. Global Contraceptive Drugs Market, growth prospects 2022-2029
• FIG 6. Global Contraceptive Drugs Market, porters 5 force model
• FIG 7. Global Contraceptive Drugs Market, pest analysis
• FIG 8. Global Contraceptive Drugs Market, value chain analysis
• FIG 9. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Contraceptive Drugs Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Contraceptive Drugs Market, regional snapshot 2019 & 2029
• FIG 15. North America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Contraceptive Drugs Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Contraceptive Drugs Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Contraceptive Drugs Market 2019 & 2029 (USD Billion)
• FIG 19. Global Contraceptive Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable